|
Overview
Based on data collected from over 540 researchers, lab directors, and executives involved in proteomics research-including participants from 13 of the
largest 15 and 19 of the largest 25 pharmaceutical companies-the CHI Proteomics Survey Report 2003 provides detailed analysis and insight into key
strategic and tactical forces driving the development and application of proteomics technologies.
The report examines all major aspects of proteomics, including protein separation, ultrafiltration, 1D and 2D gel electrophoresis, liquid
chromatography, capillary electrophoresis, mass spectrometry, protein informatics, protein arrays, protein quantification, protein localization, and
protein-protein interactions.
Survey participants provided key information on current and projected spending, their intention to adopt or drop specific proteomics technologies
and applications, detailed the advantages and disadvantages of current and emerging technological approaches to proteomics, and more.
With 70 detailed areas of analysis and over 100 color graphs, all contained within a concise 50 page report, the Proteomics Survey Report 2003 is a
uniquely efficient, primary-data grounded source of insight into the current and future state of proteomics research. (See table of contents for
specific areas of analysis.)
Methodology
Cambridge Healthtech Institute (CHI) conducted its Proteomics 2002 survey in mid-2002, and recruited a total of 542 survey participants. Survey
respondents were personally invited to participate, based on CHI' s knowledge of their interest and work in proteomics research. Survey participants
were also ensured that their participation would be kept strictly confidential, in an effort to encourage completely frank responses to often
sensitive questions. (See Appendix for list of survey participant organizations, and titles and departments.)
The survey was conducted on-line, with real-time validation of responses, and responses were gathered in a SQL database for further tabulation and
analysis. The survey was comprised of thirteen discrete sections, covering a wide range of proteomics-related research activities, and respondents
were encouraged to participate in those sections most relevant to their work and experience. As a result, the number of respondents participating in
each section of the survey varies. Accordingly, any reference in this report to a number or proportion of respondents is intended to reference the
number of substantive respondents to the particular survey question under discussion, unless otherwise noted. |